Voloridge Investment Management, LLC Bridge Bio Pharma, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $24 Million - $32.4 Million	-1,042,458 Reduced 74.65%	353,961 $8.97 Million
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $7.94 Million - $11.7 Million	290,430 Added 26.26%	1,396,419 $43.2 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $3.45 Million - $6.31 Million	-143,669 Reduced 11.5%	1,105,989 $44.6 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $13 Million - $27 Million	770,207 Added 160.64%	1,249,658 $33 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $7.48 Million - $10.1 Million	-563,035 Reduced 54.01%	479,451 $8.25 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $2.95 Million - $7.64 Million	411,775 Added 65.29%	1,042,486 $17.3 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $1.28 Million - $2.19 Million	-190,350 Reduced 23.18%	630,711 $4.81 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $5.8 Million - $9.03 Million	730,510 Added 806.74%	821,061 $8.16 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $1.83 Million - $4.27 Million	-351,412 Reduced 79.51%	90,551 $822,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $1.52 Million - $3.54 Million	206,545 Added 87.74%	441,963 $4.49 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $2.68 Million - $12.6 Million	235,418 New	235,418 $3.93 Million
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $6.6 Million - $8.61 Million	-119,021 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $1.34 Million - $2.48 Million	-34,854 Reduced 22.65%	119,021 $8.46 Million
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $2.61 Million - $4.05 Million	95,934 Added 165.57%	153,875 $5.77 Million
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $1.29 Million - $2.07 Million	57,941 New	57,941 $1.89 Million

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$721 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$717 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$405 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$355 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$173 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.23B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account